Aspirus will host a free atrial fibrillation seminar on Feb. 11 in Wausau to explain symptoms, risks, and treatment options.

Medtronic announced two new milestones for its Affera Sphere-360 catheter for pulsed field ablation (PFA) procedures.

The global ablation technology market growth is driven by rising cardiovascular and cancer cases, and the increasing adoption ...

Affera momentum continues as Medtronic announces CE Mark in Europe & US IDE first cases for Sphere-360 PFA catheter to treat paroxysmal atrial fibrillation: Galway, Ireland Tuesda ...

Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

TactiFlex Duo builds on Abbott’s electrophysiology portfolio with a catheter than can ablate irregular heart rhythms using ...

Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...

Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...

Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators of ...

Abbott received Europe’s CE mark for a dual-ablation catheter used to treat a common heart arrhythmia, the company said ...

Abbott Park, Illinois Thursday, January 22, 2026, 09:00 Hrs [IST] ...